- Price
- $4.37
- Day
- -1.35%
- Mkt Cap
- $203.59M
- 52W Range
- $1.93 – $12.46
- Volume
- 91.5K
- Beta
- -0.11
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
BURLINGTON, Mass., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced that management will participate in two upcoming investor conferences.
Read full article